TERT and melanoma: Together, our results indicate that therapeutic approaches exploiting melanoma cell addiction to TERT, and combating the ability of NRAS-mutant melanoma to offset oxidative stress, would render cancer cells vulnerable to drug-induced cell death (Fig. 7).